Objective To evaluate the antimicrobial susceptibility of different serogroups of Neisseria meningitidis (Nm) in Anhui Province during 2021-2023, and to provide reasonable basis for clinical treatment of epidemic cerebrospinal meningitis.Methods Thirty-five strains of Nm isolated and cultured from epidemic cerebrospinal meningitis cases, close contacts and healthy people in Anhui Province from 2021 to 2023 were collected, and their sensitivity to 12 kinds of antimicrobial agents was assessed by E-test.Results The sensitivity rates of 35 Nm strains to 12 drugs were 97.14% for penicillin and cefotaxime, 100.00% for ampicillin, ceftriaxone, meropenem, minocycline, azithromycin, chloramphenicol and rifampicin, 5.71% for ciprofloxacin, and 0.00% for levofloxacin and trimethoprim-sulfamethoxazole. Among them, one group B Nm insensitive to penicillin was isolated from close contact in 2022, and one serogroup nongroupable Nm insensitive to cefotaxime was isolated from healthy person in 2023.Conclusions The 35 Nm strains isolated in Anhui Province from 2021 to 2023 are generally sensitive to penicillin, ampicillin, cefotaxime, ceftriaxone, meropenem, minocycline, azithromycin, chloramphenicol and rifampicin, partially resistant to ciprofloxacin and levofloxacin, and totally resistant to trimethoprim-sulfamethoxazole. With the increasing complexity of Nm resistance in Anhui Province, long-term monitoring of Nm resistance should be carried out to guide clinical rational drug use.